Sleep Clinical Trial
— GHKOfficial title:
Generation Healthy Kids: A Cluster-randomized Trial of a Multi-component, Multi-setting Intervention to Promote Healthy Weight and Wellbeing in Danish School-aged Children
The GHK intervention was developed according to the United Kingdom Medical Research Council's framework for developing and evaluating complex interventions. A pilot- and feasibility study was conducted during December 2022-April 2023, and the intervention was subsequently adapted and adjusted. The GHK main trial is a two-school-year cluster-randomized school- and community trial designed to investigate the effect of the multi-setting, multi-component GHK intervention program on weight development, health and wellbeing in Danish children aged 6-11 years. The trial will include 24 schools in Denmark (12 intervention and 12 control). The primary aim of the cluster-randomized trial is to investigate whether the GHK intervention program can promote healthy body composition as measured by fat mass (FM) in the intervention group compared with the control group. We hypothesize that the intervention will result in less FM gain in the intervention group compared with the control group over the two school-year study period.
Status | Recruiting |
Enrollment | 1645 |
Est. completion date | December 31, 2025 |
Est. primary completion date | June 30, 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 6 Years to 11 Years |
Eligibility | Inclusion Criteria: - All children attending 1st or 2nd grade in the recruited schools Exclusion Criteria: - No exclusion criteria will be applied. If parents, teachers or research staff judge that a child cannot participate in certain parts of the intervention or measurement schedule, e.g. due to severe allergies, chronic diseases or mental/physical disabilities, the child will be eligible to participate in the remaining parts of the study. |
Country | Name | City | State |
---|---|---|---|
Denmark | 11 schools in the Capital Region of Denmark and Region Zealand | Copenhagen | Capital Region And Region Zealand |
Denmark | 12 Schools in Region of Southern Denmark | Odense | Region Of Southern Denmark |
Lead Sponsor | Collaborator |
---|---|
University of Copenhagen | Region Capital Denmark, The Novo Nordisk Foundation, University of Southern Denmark |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Health related quality of life | Between group difference in change in the total summary score of health-related quality of life measured with the KIDSCREEN 27 child self-report questionnaire. Data is collected using an adapted video and speech assisted electronic version with a smiley scale for each answer. The questionnaire assesses the child's physical well-being (5 items), psychological well-being (7 items), autonomy and parent relation (7 items), peers and social support (4 items), and school environment (4 items). | Baseline , 6-8 months, 18-20 months | |
Other | Mental health | Between group difference in change in the total difficulties score of the Strengths and difficulties questionnaire. Assessed using the parent-reported version of the Strengths and Difficulties Questionnaire. An overall total difficulties score is calculated, along with five subscale scores: emotional symptoms, conduct problems, hyperactivity/Inattention, relationship problems, and prosocial behavior. | Baseline , 6-8 months, 18-20 months | |
Other | Resting blood pressure in mmHg | Between group difference in change in systolic and diastolic blood pressure. | Baseline , 6-8 months, 18-20 months | |
Other | Resting heart rate beats/min | Between group difference in change in heart rate. | Baseline , 6-8 months, 18-20 months | |
Other | Plasma lipid profile in mmol/L | Between group difference in change in plasma total, LDL and HDL cholesterol and triacylglycerol. Only among children in DK-EAST. | Baseline and 6-8 months, (18-20 months if funding is available) | |
Other | Plasma insulin in pmol/L. | Between group difference in change in plasma insulin. Only among children in DK-EAST. | Baseline and 6-8 months, (18-20 months if funding is available) | |
Other | Plasma glucose in mmol/L. | Between group difference in change in plasma glucose. Only among children in DK-EAST. | Baseline and 6-8 months, (18-20 months if funding is available) | |
Other | Aerobic fitness and intermittent exercise performance | Between group difference in change in aerobic fitness and intermittent exercise performance. | Baseline, 6-8 months, 18-20 months | |
Other | Sprint performance | Between group difference in change in sprint performance as measured by 20 m sprint test. | Baseline, 6-8 months, 18-20 months | |
Other | Muscular fitness and strength | Between group difference in change in muscular fitness and strength. | Baseline, 6-8 months, 18-20 months | |
Other | Balance ability | Between group difference in change in balance ability. | Baseline and 18-20 months | |
Other | Jump height | Between group difference in change in jump height (countermovement jump). | Baseline and 18-20 months | |
Other | Upper and lower extremity gross motor function | Between group difference in change in Upper and lower extremity gross motor function. | Baseline and 18-20 months | |
Other | Agility | Between group difference in change in agility will be assessed using the Canadian Exercise and Movement Skills Assessment (CAMSA) | Baseline and 18-20 months | |
Other | Physically active behavior | Between group change in total time spent being physical active. Non-sedentary time is defined as any waking activity characterized as not being in a sitting, reclining or lying posture with minimal stationary movement. Activity is measured for 7 consecutive days using a thigh worn accelerometer (Axivity AX3). | Baseline, 18-20 months | |
Other | Moderate to vigorous physical activity | Between group change in time spent in moderate to vigorous physical activity. Moderate to vigorous physical activity is measured for 7 consecutive days using a thigh worn accelerometer (Axivity AX3). | Baseline, 18-20 months | |
Other | Total sleep time | Between group change in total sleep time. Sleep is measured for 7 consecutive days using a thigh worn accelerometer (Axivity AX3). | Baseline, 18-20 months | |
Other | Sleep quality | Between group difference in change in sleep quality, as measured by Child Sleep Habits Questionnaire (parent-reported). | Baseline , 6-8 months, 18-20 months | |
Other | Total screen time | Between group difference in change in total screen time (hours), as measured by modified SCREENS questionnaire (parent-reported). | Baseline , 6-8 months, 18-20 months | |
Other | Smartphone and tablet usage | Between group difference in change in smartphone/tablet usage, objectively assessed over 14 days using Ethica application. | Baseline , 6-8 months, 18-20 months | |
Other | Food literacy | Between group difference in change in child-reported using a GHK food literacy and meal culture questionnaire currently under development | Baseline, 6-8 months, 18-20 months | |
Other | School meal culture | Between group difference in change in child-reported using a GHK food literacy and meal culture questionnaire currently under development | Baseline, 6-8 months, 18-20 months | |
Other | Family meal culture | Between group difference in change in child-reported using a GHK food literacy and meal culture questionnaire currently under development | Baseline, 6-8 months, 18-20 months | |
Other | Dietary intake in g/day | Between group difference in change in dietary intake by 3-day electronic dietary record and FFQ. | Baseline, 6-8 months, 18-20 months | |
Other | n-3 long-chain polyunsaturated fatty acid (LCPUFA) status in weight% | Between group difference change in wholeblood n-3 LCPUFA status (eicosapentaenoic acid and docosahexaenoic acid). Only among children in DK-EAST. | Baseline and 6-8 months, (18-20 months if funding is available) | |
Other | Blood hemoglobin in mmol/L. | Between group difference in change in wholeblood hemoglobin (iron status). Only among children in DK-EAST. | Baseline and 6-8 months, (18-20 months if funding is available) | |
Other | Serum ferritin in ug/L. | Between group difference in change in serum ferritin (iron status). Only among children in DK-EAST. | Baseline and 6-8 months, (18-20 months if funding is available) | |
Other | Serum 25-hydroxyvitamin D in nmol/L. | Between group difference in change in serum 25-hydroxyvitamin D (vitamin D status). Only among children in DK-EAST. | Baseline and 6-8 months, (18-20 months if funding is available) | |
Other | Insulin-like growth factor-1 in ug/L. | Between group difference in change in serum insulin-like growth factor-1 (growth factor). Only among children in DK-EAST. | Baseline and 6-8 months, (18-20 months if funding is available) | |
Other | Processing speed | Performance in neuropsychological assessment of processing speed as choice reaction time (Cambridge Neuropsychological Test Automated Battery, Cambridge cognition, UK). | Baseline and 18-20 months | |
Other | Sustained attention | Performance in neuropsychological assessment of sustained attention ability assessed as errors during a sustained test procedure (Cambridge Neuropsychological Test Automated Battery, Cambridge cognition, UK). | Baseline and 18-20 months | |
Other | Spatial working memory | Performance in neuropsychological assessment of spatial working memory assessed as errors and strategy during the test procedure (Cambridge Neuropsychological Test Automated Battery, Cambridge cognition, UK). | Baseline and 18-20 months | |
Other | Inhibitory control | Performance in neuropsychological assessment of inhibitory control assessed as errors during the test procedure (Cambridge Neuropsychological Test Automated Battery, Cambridge cognition, UK). | Baseline and 18-20 months | |
Other | Cognitive flexibility | Performance in neuropsychological assessment of cognitive flexibility assessed as errors during the test procedure (Cambridge Neuropsychological Test Automated Battery, Cambridge cognition, UK). | Baseline and 18-20 months | |
Other | Fine motor control | Performance in neuropsychological assessment of fine motor control assessed as endpoint accuracy during the test procedure (Cambridge Neuropsychological Test Automated Battery, Cambridge cognition, UK). | Baseline and 18-20 months | |
Other | School performance - Danish reading comprehension | Between group difference in change in Danish reading skills (Hogrefe, Denmark). | Baseline and 18-20 months | |
Other | School performance - mathematics proficiency | Between group difference in change in mathematics proficiency (Hogrefe, Denmark). | Baseline and 18-20 months | |
Other | School absence due to sickness and other causes | Between group difference in change in number of days abscent from school due to sickness recorded in school registration data | Baseline, 6-8 months, 18-20 months | |
Other | Physical literacy | Between group difference in change in total score of physical literacy as well as for the emotional, cognitive and physical subdomain | Baseline, 18-20 months | |
Primary | Fat mass in kg | Between group difference in change in fat mass measured by air-displacement plethysmography using a BOD POD. | Baseline and 18-20 months | |
Secondary | Fat mass in kg (2) | Between group difference in change in fat mass measured by a bioimpedance analysis (InBody 270). | Baseline , 6-8 months, 18-20 months | |
Secondary | Fat free mass in kg | Between group difference in change in fat free mass measured by air-displacement plethysmography using a BOD POD. | Baseline and 18-20 months | |
Secondary | Fat free mass in kg (2) | Between group difference in change in fat free mass measured by a bioimpedance analysis (InBody 270). | Baseline , 6-8 months, 18-20 months | |
Secondary | Fat mass index in kg/m2 | Between group difference in change in fat mass index measured by air-displacement plethysmography using a BOD POD. | Baseline and 18-20 months | |
Secondary | Fat mass index in kg/m2 (2) | Between group difference in change in fat mass index measured by a bioimpedance analysis (InBody 270). | Baseline , 6-8 months, 18-20 months | |
Secondary | Fat free mass index in kg/m2 | Between group difference in change in fat free mass index measured by air-displacement plethysmography using a BOD POD. | Baseline and 18-20 months | |
Secondary | Fat free mass index in kg/m2 (2) | Between group difference in change in fat free mass index measured by a bioimpedance analysis (InBody 270). | Baseline , 6-8 months, 18-20 months | |
Secondary | Fat-Free-Mass-to-Fat-Mass ratio | Between group difference in change in FFM-to-FM ratio measured by air-displacement plethysmography using a BOD POD. | Baseline and 18-20 months | |
Secondary | Fat-Free-Mass-to-Fat-Mass ratio (2) | Between group difference in change in FFM-to-FM ratio measured by a bioimpedance analysis (InBody 270). | Baseline , 6-8 months, 18-20 months | |
Secondary | % Fat Mass | Between group difference in change in % FM in kg measured by air-displacement plethysmography using a BOD POD. | Baseline and 18-20 months | |
Secondary | % Fat Mass (2) | Between group difference in change in % FM in kg measured by a bioimpedance analysis (InBody 270). | Baseline , 6-8 months, 18-20 months | |
Secondary | Height in cm | Between group difference in change in standing height measured using a portable stadiometer. | Baseline , 6-8 months, 18-20 months | |
Secondary | Weight status in % | Between group difference in change in prevalence of children with underweight, normalweight, overweight and obesity, based on the cutoffs defined by Cole et al. and the International Task Force of Obesity. Body weight is measured by a bioimpedance analysis (InBody 270) and height by using a portable stadiometer. | Baseline , 6-8 months, 18-20 months | |
Secondary | BMI z-score | Between group difference in change in BMI z-score based on WHO references. Weight and height is measured using weight from the bioimpedance analysis (InBody 270) and a portable stadiometer, respectively. | Baseline , 6-8 months, 18-20 months | |
Secondary | Waist circumference in mm | Between group difference in change in waist circumference to the nearest mm by a non-elastic measuring tape at the level of the umbilicus. | Baseline , 6-8 months, 18-20 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04044495 -
Sleep, Rhythms and Risk of Alzheimer's Disease
|
N/A | |
Recruiting |
NCT06079853 -
Nurse Suicide: Physiologic Sleep Health Promotion Trial
|
N/A | |
Completed |
NCT05017974 -
Research on Improving Sleep During Pregnancy
|
N/A | |
Recruiting |
NCT05206747 -
Ottawa Sunglasses at Night for Mania Study
|
N/A | |
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT04513743 -
Ultra Long-Term Sleep Monitoring Using UNEEG™ Medical 24/7 EEG™ SubQ
|
N/A | |
Completed |
NCT03251274 -
Bath Machine on Sleep Quality in Nursing Home
|
N/A | |
Completed |
NCT04102345 -
Lavender vs Zolpidem Sleep Quality During Diagnostic PSG
|
Early Phase 1 | |
Completed |
NCT03725943 -
Comparison of Dreem to Clinical PSG for Sleep Monitoring in Healthy Adults
|
N/A | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Completed |
NCT04562181 -
Consistency Evaluation of the qCON, qNOX Indices and Bispectral Index
|
N/A | |
Completed |
NCT05576844 -
Ai Youmian (Love Better Sleep) for People Living With HIV
|
N/A | |
Completed |
NCT05102565 -
A Dyadic Telehealth Program for Alzheimer's Patients/Caregivers
|
N/A | |
Completed |
NCT04688099 -
Synovial Fluid Sleep Study
|
||
Recruiting |
NCT04171245 -
Prescribing Laughter for Sleep and Wellbeing in UAE University Students
|
N/A | |
Completed |
NCT03758768 -
The Effects of a Blue Monochromatic Light Intervention on Evening-type Individuals' Sleep and Circadian Rhythms
|
N/A | |
Completed |
NCT03163498 -
Evaluation of Sleep Pattern and Mood Profile in Hypertensive Patients
|
||
Completed |
NCT04093271 -
Investigating the Efficacy of Rest-ZZZ Formula in Healthy Participants With Difficulty Falling Asleep or Staying a Sleep
|
Phase 1 | |
Completed |
NCT03673397 -
The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression
|
N/A | |
Completed |
NCT04120363 -
Trial of Testosterone Undecanoate for Optimizing Performance During Military Operations
|
Phase 4 |